A method for preparing a zeolite catalyst for catalytic cracking of hydrocarbons to produce propylene is provided, which specifically includes steps of mixing a silicon source, a templating agent, an aluminium source, and a solvent to form a zeolite precursor solution, which is then subjected to hydrothermal crystallization, washing, drying, and calcination to obtain a zeolite precursor; ion-exchanging the zeolite precursor with ammonium ions, followed by drying and calcination; and loading aluminum onto the ion-exchanged zeolite precursor as a carrier via incipient-wetness impregnation by using an aluminium-containing solution, followed by drying and calcination. Zeolite catalysts prepared by the method and use of the catalysts in catalytic cracking of hydrocarbons to produce propylene are also provided.

The invention provides a method for the production of a zeolite particle composition which has optimized characteristics, such as enhanced adsorption and specific ion exchange properties. A method and an apparatus for producing improved zeolite particle compositions are provided, where the particles are treated with an oxygen-containing gas during micronisation. The zeolite particle compositions can be used in a method for treatment of the human or animal body by therapy and/or prophylaxis, and specifically in a method of treating or preventing conditions of the human or animal body or symptoms of these conditions that are related to heavy metals, endotoxins, exotoxins, and/or bacterial, viral or parasitic intoxications in or of the digestive system, mucosal surfaces or the skin. Also, new zeolite particle compositions can be used as food additive, as filter for purification of water, in packaging materials, or as cosmetic ingredient.

The invention provides a method for the production of a zeolite particle composition which has optimized characteristics, such as enhanced adsorption and specific ion exchange properties. A method and an apparatus for producing improved zeolite particle compositions are provided, where the particles are treated with an oxygen-containing gas during micronisation. The zeolite particle compositions can be used in a method for treatment of the human or animal body by therapy and/or prophylaxis, and specifically in a method of treating or preventing conditions of the human or animal body or symptoms of these conditions that are related to heavy metals, endotoxins, exotoxins, and/or bacterial, viral or parasitic intoxications in or of the digestive system, mucosal surfaces or the skin. Also, new zeolite particle compositions can be used as food additive, as filter for purification of water, in packaging materials, or as cosmetic ingredient.

An aluminum-rich molecular sieve material of MFS framework type, designated SSZ-123, is provided. SSZ-123 can be synthesized using 1-ethyl-1-[5-(triethylammonio)pentyl]piperidinium cations as a structure directing agent. SSZ-123 may be used in organic compound conversion and/or sorptive processes.

Disclosed are zeolite catalysts having the CHA crystal structure with a low silica to alumina ratio, as well as articles and systems incorporating the catalysts and methods for their preparation and use. The catalysts can be used to reduce NOx from exhaust gas streams, particularly those emanating from gasoline or diesel engines.

Catalyst composition which comprises a first zeolite having a BEA* framework type and a second zeolite having a MOR framework type and a mesopore surface area of greater than 30 m.sup.2/g is disclosed. These catalyst compositions are used to remove catalyst poisons from untreated feed streams having one or more impurities which cause deactivation of the downstream catalysts employed in hydrocarbon conversion processes, such as those that produce mono-alkylated aromatic compounds.

Catalyst composition which comprises a first zeolite having a BEA* framework type and a second zeolite having a MOR framework type and a mesopore surface area of greater than 30 m.sup.2/g is disclosed. These catalyst compositions are used to remove catalyst poisons from untreated feed streams having one or more impurities which cause deactivation of the downstream catalysts employed in hydrocarbon conversion processes, such as those that produce mono-alkylated aromatic compounds.

The present invention is directed to a method of preparing a molecular sieve of SWY framework type, denominated STA-30. STA-30 is synthesized using 1,4-diazabicyclo[2.2.2]octane, 1-azabicyclo[2.2.2]octane derivates and combinations thereof as structure directing agents. The resulting molecular sieve is useful as catalysts, particularly when used in combination with exchanged transition metal(s) for the Selective Catalytic Reduction (SCR) of NO

The present invention is directed to a method of preparing a molecular sieve of SWY framework type, denominated STA-30. STA-30 is synthesized using 1,4-diazabicyclo[2.2.2]octane, 1-azabicyclo[2.2.2]octane derivates and combinations thereof as structure directing agents. The resulting molecular sieve is useful as catalysts, particularly when used in combination with exchanged transition metal(s) for the Selective Catalytic Reduction (SCR) of NO

A novel synthetic crystalline aluminogermanosilicate molecular sieve material, designated SSZ-116, is provided. SSZ-116 can be synthesized using 3-[(3,5-di-tert-butylphenyl)methyl]-1,2-dimethyl-1H-imidazolium cations as a structure directing agent. SSZ-116 may be used in organic compound conversion reactions and/or sorptive processes.